| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 667899 | Null | 0.0247898374452139 | 0.3362322 |
| NSC 667904 | 1-(8-(2,3-dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)-2-phenylhydrazine | 0.0247898374452139 | 0.34333605 |
| NSC 668476 | Null | 0.0247898374452139 | 0.074047994 |
| NSC 669888 | Null | 0.0247898374452139 | 0.27171407 |
| NSC 677672 | Null | 0.0247898374452139 | 0.067604036 |
| NSC 678355 | L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 | 0.0247898374452139 | 0.12878568 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0247898374452139 | 0.38035791 |
| NSC 681636 | Camptothecin Derivative | 0.0247898374452139 | 0.065275311 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.0247898374452139 | 0.47272525 |
| NSC 683608 | Null | 0.0247898374452139 | 0.4465099 |